409 related articles for article (PubMed ID: 7594082)
1. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
Mehra MR; Ventura HO; Jain SP; Ramireddy K; Ali A; Stapleton DD; Smart FW; Ramee SR; Collins TJ; White CJ
J Am Coll Cardiol; 1997 May; 29(6):1339-44. PubMed ID: 9137233
[TBL] [Abstract][Full Text] [Related]
3. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
Escobar A; Ventura HO; Stapleton DD; Mehra MR; Ramee SR; Collins TJ; Jain SP; Smart FW; White CJ
Am J Cardiol; 1994 Nov; 74(10):1042-6. PubMed ID: 7977044
[TBL] [Abstract][Full Text] [Related]
4. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Stapleton DD; Smart FW; Collins TC; Ramee SR
J Heart Lung Transplant; 1995; 14(4):632-9. PubMed ID: 7578168
[TBL] [Abstract][Full Text] [Related]
5. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
7. Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Stapleton DD; Karsan AK; Smart FW; Ramee SR; Collins TJ
Am Heart J; 1997 Jun; 133(6):698-702. PubMed ID: 9200398
[TBL] [Abstract][Full Text] [Related]
8. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.
Mehra MR; Ventura HO; Uber PA; Scott RL; Park MH
J Heart Lung Transplant; 2003 Feb; 22(2):118-23. PubMed ID: 12581758
[TBL] [Abstract][Full Text] [Related]
9. Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.
Martí V; Romeo I; Aymat R; García J; Guiteras P; Ballester M; Aminian N; Caralps JM; Augé JM
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1174-80. PubMed ID: 11726893
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
[TBL] [Abstract][Full Text] [Related]
11. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.
Mehra MR; Uber PA; Ventura HO; Scott RL; Park MH
J Am Coll Cardiol; 2004 Mar; 43(5):806-10. PubMed ID: 14998621
[TBL] [Abstract][Full Text] [Related]
12. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
[TBL] [Abstract][Full Text] [Related]
13. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
[TBL] [Abstract][Full Text] [Related]
14. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.
Tuzcu EM; Kapadia SR; Sachar R; Ziada KM; Crowe TD; Feng J; Magyar WA; Hobbs RE; Starling RC; Young JB; McCarthy P; Nissen SE
J Am Coll Cardiol; 2005 May; 45(9):1538-42. PubMed ID: 15862431
[TBL] [Abstract][Full Text] [Related]
15. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study.
Jimenez J; Kapadia SR; Yamani MH; Platt L; Hobbs RE; Rincon G; Botts-Silverman C; Starling RC; Young JB; Nissen SE; Tuzcu M; Ratliff NB
J Heart Lung Transplant; 2001 Apr; 20(4):393-8. PubMed ID: 11295576
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
[TBL] [Abstract][Full Text] [Related]
17. Vascular remodeling 1 year after cardiac transplantation.
Li H; Tanaka K; Chhabra A; Oeser B; Kobashigawa JA; Tobis JM
J Heart Lung Transplant; 2007 Jan; 26(1):56-62. PubMed ID: 17234518
[TBL] [Abstract][Full Text] [Related]
18. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
[TBL] [Abstract][Full Text] [Related]
19. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.
Blanco-García RM; López-Álvarez MR; Garrido IP; Salgado-Cecilia G; Campillo JA; Bolarín JM; Gimeno L; Muro M; García-Alonso AM; Martínez-Sánchez MV; Bernardo Pisa MV; Soriano-Díaz S; Pascual-Figal DA; Alvarez-López MR; Minguela A
Hum Immunol; 2013 Mar; 74(3):318-24. PubMed ID: 23247208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
